Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan-Reference-Cited by-同舟云学术

Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan

Published:2022-10-10 Issue:12 Volume:113 Page:4258-4266
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Ikezoe Takayuki¹,Ando Kiyoshi²,Onozawa Masahiro³,Yamane Takahisa⁴,Hosono Naoko⁵,Morita Yasuyoshi⁶,Kiguchi Toru⁷,Iwasaki Hiromi⁸,Miyamoto Toshihiro⁹^ORCID,Matsubara Keisuke¹⁰,Sugimoto Saori¹⁰,Miyazaki Yasushi¹¹^ORCID,Kizaki Masahiro¹²,Akashi Koichi⁹

Affiliation:

1. Department of Hematology Fukushima Medical University Hospital Fukushima Japan

2. Department of Hematology and Oncology Tokai University Tokyo Japan

3. Department of Hematology Hokkaido University Hospital Sapporo Japan

4. Department of Hematology Osaka City General Hospital Osaka Japan

5. Department of Hematology and Oncology University of Fukui Hospital Fukui Japan

6. Department of Hematology and Rheumatology Kindai University Hospital Osaka‐Sayama Japan

7. Department of Hematology Chugoku Central Hospital Fukuyama Japan

8. Department of Hematology, National Hospital Organization Kyushu Medical Center Fukuoka Japan

9. Department of Medicine and Biosystemic Science Faculty of Medicine Kyushu University Fukuoka Japan

10. Sumitomo Pharma Co., Ltd. Tokyo Japan

11. Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute Nagasaki University Nagasaki Japan

12. Department of Hematology, Saitama Medical Center Saitama Medical University Saitama Japan

Funder

Dainippon Sumitomo Pharma

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15458

Reference20 articles.

1. ‘Acute myeloid leukemia: a comprehensive review and 2016 update’

2. International Agency for Research on Cancer.Globocan Factsheet 2020: Japan.https://gco.iarc.fr/today/data/factsheets/populations/392‐japan‐fact‐sheets.pdf. Accessed October 30 2021.

3. Type distribution of myeloid leukemia from Cancer Incidence in Five Continents Vol. X

4. National Comprehensive Cancer Network.NCCN clinical practice guidelines in oncology: Acute myeloid leukemia. Version 3.2021.https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf. Accessed October 30 2021.

5. Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review